Search by First Name and/or Last Name. Results are displayed in descending publication year and then sorted ascending by the reference field. Need to submit a publication reference?
Name: Audrey Keleman
Year: 2020
Reference:
Keleman, A., Wisch, J. K., Bollinger, R. M., Grant, E. A., Benzinger, T. L., Morris, J. C., Ances, B.A., & Stark, S. L. Falls Associate with Neurodegenerative Changes in ATN Framework of Alzheimer’s Disease. Journal of Alzheimer’s disease 2020; 77(2): 745-752. PMID: 32741815.
Name: Cyrus Raji
Year: 2020
Reference:
Lauren N Koenig 1, Gregory S Day 2, Amber Salter 1, Sarah Keefe 1, Laura M Marple 1, Justin Long 2, Pamela LaMontagne 1, Parinaz Massoumzadeh 2, B Joy Snider 2, Manasa Kanthamneni 3, Cyrus A Raji 2, Nupur Ghoshal 2, Brian A Gordon 2, Michelle Miller-Thomas 1, John C Morris 2, Joshua S Shimony 1, Tammie L S Benzinger 4, Alzheimer’s Disease Neuroimaging Initiative (ADNI) and the Dominantly Inherited Alzheimer Network (DIAN)
Select Atrophied Regions in Alzheimer disease (SARA): An improved volumetric model for identifying Alzheimer disease dementia
Neuroimage Clin
. 2020;26:102248. doi: 10.1016/j.nicl.2020.102248. Epub 2020 Mar 16.
PMID: 32334404 PMCID: PMC7182765 DOI: 10.1016/j.nicl.2020.102248
Name: Anne Fagan
Year: 2020
Reference:
Luo J, Agboola F, Grant E, Masters CL, Albert MS, Johnson SC, McDade EM, Vöglein J, Fagan AM, Benzinger T, Massoumzadeh P, Hassenstab J, Bateman RJ, Morris JC, Perrin RJ, Chhatwal J, Jucker M, Ghetti B, Cruchaga C, Graff-Radford NR, Schofield PR, Mori H, Xiong C. Neurology. 2020 Sep 1. PMID: 32873693. Sequence of Alzheimer disease biomarker changes in cognitively normal adults: A cross-sectional study.
Name: Anne Fagan
Year: 2020
Reference:
Luo J, Agboola F, Grant E, Masters CL, Albert MS, Johnson SC, McDade EM, Vöglein J, Fagan AM, Benzinger T, Massoumzadeh P, Hassenstab J, Bateman RJ, Morris JC, Perrin RJ, Chhatwal J, Jucker M, Ghetti B, Cruchaga C, Graff-Radford NR, Schofield PR, Mori H, Xiong C. Neurology. 2020 Sep 1. PMID: 32873693. Sequence of Alzheimer disease biomarker changes in cognitively normal adults: A cross-sectional study.
Name: Anne Fagan
Year: 2020
Reference:
Marta Stojanovic, Yuxuan Jin, Fagan AM, Tammie L Benzinger, Jason Hassenstab, Carlos Cruchaga, John C Morris, Denise Head. Physical Exercise and Longitudinal Trajectories in Alzheimer Disease Biomarkers and Cognitive Functioning. Alzheimer Disease and Associated Disorders. 2020 Jun 9. PMCID: PMC7483844.
Name: Peter Millar
Year: 2020
Reference:
Millar, PR, Ances, BM, Gordon, BA, Benzinger, TLS, Fagan, AM, Morris, JC, & Balota, DA (2020). Evaluating resting-state BOLD variability in relation to biomarkers of preclinical Alzheimer disease. Neurobiology of Aging, 96, 233-45. DOI: 10.1016/j.neurobiolaging.2020.08.007 PMCID: PMC7877894 PMID: 33039901.
Name: Peter Millar
Year: 2020
Reference:
Millar, PR, Petersen, SE, Ances, BM, Gordon, BA, Benzinger, TLS, Morris, JC, & Balota, DA (2020). Evaluating the sensitivity of resting-state BOLD variability to age and cognition after controlling for motion and cardiovascular influences: A network-based approach. Cerebral Cortex, 30 (11), 5686-5701. DOI: 10.1093/cercor/bhaa138 PMCID: PMC7822708 PMID: 32515824.
Name: Anne Fagan
Year: 2020
Reference:
Rachel L. Henson, Eric Doran, Bradley T. Christian, Benjamin L. Handen, William E. Klunk, Florence Lai, Joseph H. Lee, H. Diana Rosas, Nicole Schupf,, Shahid H. Zaman, Ira T. Lott, and Fagan AM. Cerebrospinal fluid biomarkers of Alzheimer’s disease in a cohort of adults with Down syndrome.
Alzheimers Dementia (Amst). 2020; 12(1): e12057. PMCID: PMC7346867.
Name: Anne Fagan
Year: 2020
Reference:
Stephanie A Schultz , Jeremy F Strain , Adedamola Adedokun , Qing Wang , Oliver Preische , Jens Kuhle , Shaney Flores , Sarah Keefe , Aylin Dincer , Beau M Ances , Sarah B Berman , Adam M Brickman , David M Cash , Jasmeer Chhatwal , Carlos Cruchaga , Michael Ewers , Nick N Fox , Bernardino Ghetti , Alison Goate , Neill R Graff-Radford , Jason J Hassenstab , Russ Hornbeck , Clifford Jack Jr , Keith Johnson , Nelly Joseph-Mathurin , Celeste M Karch , Robert A Koeppe , Athene K W Lee , Johannes Levin , Colin Masters , Eric McDade , Richard J Perrin , Christopher C Rowe , Stephen Salloway , Andrew J Saykin , Reisa Sperling , Yi Su , Victor L Villemagne , Jonathan Vöglein , Michael Weiner, Chengjie Xiong , Fagan AM , John C Morris , Randall J Bateman , Tammie L S Benzinger , Mathias Jucker , Brian A Gordon , Dominantly Inherited Alzheimer Network. Serum Neurofilament Light Chain Levels Are Associated With White Matter Integrity in Autosomal Dominant Alzheimer’s Disease. Neurobiology of Disease. 2020 Jun 6;142:104960. PMCID: PMC6367005.
Name: Anne Fagan
Year: 2019
Reference:
Franzmeier N, Ren J, Damm A, Monté-Rubio G, Boada M, Ruiz A, Ramirez A, Jessen F, Düzel E, Rodríguez Gómez O, Benzinger T, Goate A, Karch CM, Fagan AM, McDade E, Buerger K, Levin J, Duering M, Dichgans M, Suárez-Calvet M, Haass C, Gordon BA, Lim YY, Masters CL, Janowitz D, Catak C, Wolfsgruber S, Wagner M, Milz E, Moreno-Grau S, Teipel S, Grothe MJ, Kilimann I, Rossor M, Fox N, Laske C, Chhatwal J, Falkai P, Perneczky R, Lee JH, Spottke A, Boecker H, Brosseron F, Fliessbach K, Heneka MT, Nestor P, Peters O, Fuentes M, Menne F, Priller J, Spruth EJ, Franke C, Schneider A, Westerteicher C, Speck O, Wiltfang J, Bartels C, Araque Caballero MÁ, Metzger C, Bittner D, Salloway S, Danek A, Hassenstab J, Yakushev I, Schofield PR, Morris JC, Bateman RJ, Ewers M The BDNFVal66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer’s disease. Molecular Psychiatry. 2019 Mar 21. PMID: 30899092
Name: Yo-El Ju
Year: 2019
Reference:
Ju YS, Zangrilli MA, Finn MB, Fagan AM, Holtzman DM. Obstructive sleep apnea
treatment, slow wave activity, and amyloid-β. Ann Neurol. 2018 Dec 31. doi:
10.1002/ana.25408. [Epub ahead of print] PubMed PMID: 30597615.
Name: Anne Fagan
Year: 2019
Reference:
Ju YS, Zangrilli MA, Finn MB, Fagan AM, Holtzman DM. Obstructive sleep apnea treatment, slow wave activity, and amyloid-β. Ann Neurol. 2019 Feb;85(2):291-295. PMCID: PMC6396979
Name: Anne Fagan
Year: 2019
Reference:
Llibre-Guerra JJ, Li Y, Schindler SE, Gordon BA, Fagan AM, Morris JC, Benzinger TLS, Hassenstab J, Wang G, Allegri R, Berman SB, Chhatwal J, Farlow MR, Holtzman DM, Jucker M, Levin J, Noble JM, Salloway S, Schofield P, Karch C, Fox NC, Xiong C, Bateman RJ, McDade E. Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer Disease. JAMA Netw Open. 2019 Dec 2;2(12):e1917126. PMID: 31825500
Name: Justin Long
Year: 2019
Reference:
Long JM, Holtzman DM. Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. Cell. 2019 Sep 25. PMID: 31564456.
Name: Anne Fagan
Year: 2019
Reference:
Preische O, Schultz SA, Apel A, Kuhle J, Kaeser SA, Barro C, Gräber S, Kuder-Buletta E, LaFougere C, Laske C, Vöglein J, Levin J, Masters CL, Martins R, Schofield PR, Rossor MN, Graff-Radford NR, Salloway S, Ghetti B, Ringman JM, Noble JM, Chhatwal J, Goate AM, Benzinger TLS, Morris JC, Bateman RJ, Wang G, Fagan AM, McDade EM, Gordon BA, Jucker M; Dominantly Inherited Alzheimer Network. Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease. Nature Medicine. 2019 25(2):277-283 PMCID: PMC6367005
Name: Anne Fagan
Year: 2019
Reference:
Preische O, Schultz SA, Apel A, Kuhle J, Kaeser SA, Barro C, Gräber S, Kuder-Buletta E, LaFougere C, Laske C, Vöglein J, Levin J, Masters CL, Martins R, Schofield PR, Rossor MN, Graff-Radford NR, Salloway S, Ghetti B, Ringman JM, Noble JM, Chhatwal J, Goate AM, Benzinger TLS, Morris JC, Bateman RJ, Wang G, Fagan AM, McDade EM, Gordon BA, Jucker M; Dominantly Inherited Alzheimer Network. Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease. Nature Medicine. 2019 25(2):277-283 PMCID: PMC6367005
Name: Anne Fagan
Year: 2019
Reference:
Tsai RM, Miller Z, Koestler M, Rojas JC, Ljubenkov PA, Rosen HJ, Rabinovici GD, Fagan AM, Cobigo Y, Brown JA, Jung JI, Hare E, Geldmacher DS, Natelson-Love M, McKinley EC, Luong PN, Chuu EL, Powers R, Mumford P, Wolf A, Wang P, Shamloo M, Miller BL, Roberson ED, Boxer AL. Reactions to Multiple Ascending Doses of the Microtubule Stabilizer TPI-287 in Patients With Alzheimer Disease, Progressive Supranuclear Palsy, and Corticobasal Syndrome: A Randomized Clinical Trial. JAMA Neurology. 2019 Nov 11
Name: Anne Fagan
Year: 2019
Reference:
Wang G, Coble D, McDade EM, Hassenstab J, Fagan AM, Benzinger TLS, Bateman RJ, Morris JC, Xiong C; Dominantly Inherited Alzheimer Network (DIAN). Staging biomarkers in preclinical autosomal dominant Alzheimer’s disease by estimated years to symptom onset. Alzheimers Dementia. 2019 Feb 14. pii: S1552-5260(18)33625-2. PMCID: PMC6461496
Name: Anne Fagan
Year: 2018
Reference:
Araque Caballero MÁ, Suárez-Calvet M, Duering M, Franzmeier N, Benzinger T, Fagan AM, Bateman RJ, Jack CR, Levin J, Dichgans M, Jucker M, Karch C, Masters CL, Morris JC, Weiner M, Rossor M, Fox NC, Lee JH, Salloway S, Danek A, Goate A, Yakushev I, Hassenstab J, Schofield PR, Haass C, Ewers M. White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease. Brain. 2018 Oct 1;141(10):3065-3080. PMCID: PMC6158739
Name: Andrew Aschenbrenner
Year: 2018
Reference:
Aschenbrenner, A.J., Gordon, B.A., Benzinger, T.L.S, Morris, J. C., & Hassenstab, J. (in press). Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease. Neurology
Name: Brian Gordon
Year: 2018
Reference:
Day, GS, Gordon, BA, Perrin, RJ, Cairns, NJ, Beaumont, H, Schwetye, K, Ferguson, C, Sinha, N, Bucelli, R, Musiek, ES, Ghoshal, N, Rosana Ponisio, M, Vincent, B, Mishra, S, Jackson, K, Morris, JC, Benzinger, TLS, Ances, BM. (in press) [18F]-AV-1451 PET imaging in pathologically-confirmed sporadic Creutzfeldt-Jakob disease. Neurology.
Name: Brian Gordon
Year: 2018
Reference:
Gordon, BA, Blazey TM*, Su, Y, et al. (2018). Spatial patterns of longitudinal neuroimaging biomarker change in autosomal dominant Alzheimer disease. Lancet Neurology.17(3):241-250
Name: Brian Gordon
Year: 2018
Reference:
Gordon, BA, McCullough, A, Mishra, S, Blazey, TM, Su, Y, Christensen, J, Dincer, A, Jackson, K, Hornbeck, RC, Morris, JC, Ances, B, Benzinger, TLS (in press). Cross-sectional and longitudinal atrophy is preferentially associated with tau rather than Aβ PET pathology. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring.
Name: Brian Gordon
Year: 2018
Reference:
Gordon, BA. 2018. Measures of metabolism provide insights into hippocampal sclerosis. Brain.
Name: Anne Fagan
Year: 2018
Reference:
Hansson O, Mikulskis A, Fagan AM, Teunissen C, Zetterberg H, Vanderstichele H, Molinuevo JL, Shaw LM, Vandijck M, Verbeek MM, Savage M, Mattsson N, Lewczuk P, Batrla R, Rutz S, Dean RA, Blennow K. The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer’s disease diagnosis: A review. Alzheimers Dement. 2018 Jun 22. pii: S1552-5260(18)30162-6. PMID: 29940161